stella
beta
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy — Stella
Home
/
Psoriatic Arthritis
/
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
View on ClinicalTrials.gov
Recruiting
Back to Psoriatic Arthritis trials
Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
United States
University of California, San Diego, San Diego, California